Immune-mediated necrotizing myopathies are serologically heterogeneous and autoantibodies may predict their clinical phenotype: Two cases associated with anti-Pl7 antibodies

Scandinavian Journal of Rheumatology

Volumn 43, Issue 1, 2014, Pages 81-83

  Meyer, A ^a   Messer, L ^b   Goetz, J ^a   Lannes, B ^a   Weber, J C ^a   Geny, B ^a   Gottenberg, J E ^a   Sibilia, J ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Rheumatology Office   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CREATINE KINASE; ENZYME ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; JO 1 ANTIBODY; METHOTREXATE; PL7 ANTIBODY; PREDNISONE; PROTEIN ANTIBODY; SIGNAL RECOGNITION PARTICLE; UNCLASSIFIED DRUG;

ARTHRALGIA; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DYSPNEA; ELECTROMYOGRAPHY; FOLLOW UP; HEP 2 CELL; HUMAN; IMMUNE MEDIATED NECROTIZING MYOPATHY; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; LETTER; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NECROSIS; PRIORITY JOURNAL; PROGNOSIS; RASH; RAYNAUD PHENOMENON; RELAPSE; REMISSION; SEROLOGY;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; MIDDLE AGED; MUSCULAR DISEASES; PHENOTYPE;

EID: 84892983402     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.864421     Document Type: Letter

References (10)

1. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol 2012;24:602-8.
2. Ellis E, Ann Tan J, Lester S, Tucker G, Blumbergs P, Roberts- Thomson P, et al. Necrotizingmyopathy: clinicoserologic associations. Muscle Nerve 2012;45:189-94.
3. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010;62:2757-66.
4. Mehndiratta P, Mehta S, Manjila SV, Kammer GM, Cohen ML, Preston DC. Isolated necrotizing myopathy associated with anti- PL12 antibody. Muscle Nerve 2012;46:282-6.
5. Szodoray P, Varoczy L, Papp G, Barath S, Nakken B, Szegedi G, et al. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases. Scand J Rheumatol 2012;41:110-15.
6. Mathiesen P, Hegaard H, Herlin T, Zak M, Pedersen FK, Nielsen S. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study. Scand J Rheumatol 2012;41:50-8.
7. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatr 2000;68:472-8. (Pubitemid 30248747)
8. Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) 2012;91:206-11.
9. Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest 2009;135:1550-6.
10. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 2012;12:210-17.